AUSTIN, Texas, Jan. 4, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group B Streptococcus (GBS) Assay for antepartum detection of GBS colonization in pregnant women. This is the third assay the FDA has cleared for use on the Luminex ARIES® Systems. The company has also... Read more
AUSTIN, Texas, Jan. 4, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group B Streptococcus (GBS) Assay for antepartum detection of GBS colonization in pregnant women. This is the third assay the FDA has cleared for use on the Luminex ARIES® Systems. The company has also... Read more
MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics in Wuhan, has agreed to purchase five additional Sequel™ instruments to support China’s precision medicine initiative, with a specific focus on ultimately providing the genetic... Read more
SANTA CLARA, Calif.–(BUSINESS WIRE)–Jan. 3, 2017– Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: Healthcare CEOs Unscripted: A View from the TopInterContinental Hotel BostonThursday, Jan. 5, 2017, at 1 p.m. (ET)Mike McMullen, Agilent president and chief executive officer A link to the webcast will be available at www.investor.agilent.com. About Agilent TechnologiesAgilent Technologies Inc. (NYSE: A), a global... Read more
Consolidation of Cold Chain Technologies Enables External Investment in evo™ Smart Shipper and biologistex SaaS Opportunity BOTHELL, Wash., Jan. 3, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers (“BioLife”) today announced the restructuring of... Read more
SANTA CLARA, Calif.–(BUSINESS WIRE)–Jan. 3, 2017– Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: 35thAnnual J.P. Morgan Healthcare ConferenceWestin St. Francis Hotel, San Francisco, CaliforniaTuesday, Jan. 10, 2017, at 3:00 p.m. PTMike McMullen, Agilent president and chief executive officer A link to the webcast will be available at www.investor.agilent.com.... Read more
CHALFONT ST. GILES, UK – 3 January, 2017 – GE Healthcare’s Life Sciences business announced today that it has acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan® (regadenoson) in territories outside the USA, Canada and Mexico. GE Healthcare’s strong industry presence and existing customer and... Read more
«Everybody should be able to benefit from the power of ion chromatography» – that is the idea of the Metrohm Eco IC. Focusing on the essentials, this new instrument provides the very best of ion chromatography at a very affordable price. Stripped from the «bells and whistles» of sophisticated high-end instrumentation, the Eco IC... Read more
Paragon Genomics, a life sciences company dedicated to improving the critical upfront target enrichment and library preparation workflow for Next-Generation Sequencing and moving precision medicine forward, graduated from Stanford’s Fall 2016 StartX Accelerator Program. StartX Accelerator Program is a highly-intensive, 16-week program that accepts just 7-8 percent of applicants for its Spring and Fall sessions each year. The Founders of the Company has received... Read more
Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more